Literature DB >> 17764934

Design and synthesis of 7-hydroxy-1H-benzoimidazole derivatives as novel inhibitors of glycogen synthase kinase-3beta.

Dongkyu Shin1, Seung-Chul Lee, Yong-Seok Heo, Woon-Young Lee, Yong-Soon Cho, Yong Eun Kim, Young-Lan Hyun, Joong Myung Cho, Yoon Sup Lee, Seonggu Ro.   

Abstract

A hydroxy functional group was introduced as the hydrogen bond donor and acceptor at the hinge region of protein kinase in order to develop novel ATP-competitive inhibitors. Several derivatives of 7-hydroxyl-1H-benzoimidazole were designed as inhibitors of glycogen synthase kinase-3beta with the help of ab initio calculations and a docking study. Enzymatic assay and an X-ray complex study showed that these designed compounds were highly potent ATP-competitive inhibitors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17764934     DOI: 10.1016/j.bmcl.2007.07.056

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  11 in total

1.  Identification of Novel 2,4,5-Trisubstituted Pyrimidines as Potent Dual Inhibitors of Plasmodial PfGSK3/PfPK6 with Activity against Blood Stage Parasites In Vitro.

Authors:  Kareem A Galal; Anna Truong; Frank Kwarcinski; Chandi de Silva; Krisha Avalani; Tammy M Havener; Michael E Chirgwin; Eric Merten; Han Wee Ong; Caleb Willis; Ahmad Abdelwaly; Mohamed A Helal; Emily R Derbyshire; Reena Zutshi; David H Drewry
Journal:  J Med Chem       Date:  2022-09-27       Impact factor: 8.039

2.  Use of molecular modeling, docking, and 3D-QSAR studies for the determination of the binding mode of benzofuran-3-yl-(indol-3-yl)maleimides as GSK-3beta inhibitors.

Authors:  Ki Hwan Kim; Irina Gaisina; Franck Gallier; Denise Holzle; Sylvie Y Blond; Andrew Mesecar; Alan P Kozikowski
Journal:  J Mol Model       Date:  2009-05-14       Impact factor: 1.810

Review 3.  Glycogen synthase kinase 3: more than a namesake.

Authors:  Geetha Vani Rayasam; Vamshi Krishna Tulasi; Reena Sodhi; Joseph Alex Davis; Abhijit Ray
Journal:  Br J Pharmacol       Date:  2009-03-04       Impact factor: 8.739

4.  GSK-3β: A Bifunctional Role in Cell Death Pathways.

Authors:  Keith M Jacobs; Sandeep R Bhave; Daniel J Ferraro; Jerry J Jaboin; Dennis E Hallahan; Dinesh Thotala
Journal:  Int J Cell Biol       Date:  2012-05-21

5.  Flavonoids modulate multidrug resistance through wnt signaling in P-glycoprotein overexpressing cell lines.

Authors:  S Mohana; M Ganesan; N Rajendra Prasad; D Ananthakrishnan; D Velmurugan
Journal:  BMC Cancer       Date:  2018-11-26       Impact factor: 4.430

6.  Pramipexole prevents ischemic cell death via mitochondrial pathways in ischemic stroke.

Authors:  Syed Suhail Andrabi; Mubashshir Ali; Heena Tabassum; Sabiha Parveen; Suhel Parvez
Journal:  Dis Model Mech       Date:  2019-08-29       Impact factor: 5.758

7.  Small-Molecule Inhibitors of GSK-3: Structural Insights and Their Application to Alzheimer's Disease Models.

Authors:  Thomas Kramer; Boris Schmidt; Fabio Lo Monte
Journal:  Int J Alzheimers Dis       Date:  2012-07-22

8.  4-Aminoethylamino-emodin--a novel potent inhibitor of GSK-3beta--acts as an insulin-sensitizer avoiding downstream effects of activated beta-catenin.

Authors:  Rolf Gebhardt; Katja S Lerche; Frank Götschel; Robert Günther; Jens Kolander; Lars Teich; Sebastian Zellmer; Hans-Jörg Hofmann; Kurt Eger; Andreas Hecht; Frank Gaunitz
Journal:  J Cell Mol Med       Date:  2009-10-03       Impact factor: 5.310

Review 9.  Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging.

Authors:  Mukesh K Pandey; Timothy R DeGrado
Journal:  Theranostics       Date:  2016-02-17       Impact factor: 11.556

10.  Nrf2/HO-1 mediates the neuroprotective effects of pramipexole by attenuating oxidative damage and mitochondrial perturbation after traumatic brain injury in rats.

Authors:  Mohd Salman; Heena Tabassum; Suhel Parvez
Journal:  Dis Model Mech       Date:  2020-08-19       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.